For example, when Tysabri was pushing for fast track approval in the US, they also tried here in Canada. The FDA approved fast-tracking and I am sure we all remember how that turned out. In Canada, fast tracking was refused with the result that we didn't see a drug pulled off the shelves after approval because of the PML link.
Not only is Health Canada not influenced by big pharma, I've been told that they aren't too impressed with the data that Biogen submits...hence the additional caution.
BTW, I see that your messages have "Carpe Diem" on them. That is the motto of a high school here in London, ON...did you by chance ever attend MTS high school?